2wzb › Citations

Transition state analogue structures of human phosphoglycerate kinase establish the importance of charge balance in catalysis.

Cliff MJ, Bowler MW, Varga A, Marston JP, Szabó J, Hounslow AM, Baxter NJ, Blackburn GM, Vas M, Waltho JP
J Am Chem Soc 132 6507-16 (2010)
Related entries: 2wzc, 2wzd

Cited: 53 times
EuropePMC logo PMID: 20397725

Abstract

Transition state analogue (TSA) complexes formed by phosphoglycerate kinase (PGK) have been used to test the hypothesis that balancing of charge within the transition state dominates enzyme-catalyzed phosphoryl transfer. High-resolution structures of trifluoromagnesate (MgF(3)(-)) and tetrafluoroaluminate (AlF(4)(-)) complexes of PGK have been determined using X-ray crystallography and (19)F-based NMR methods, revealing the nature of the catalytically relevant state of this archetypal metabolic kinase. Importantly, the side chain of K219, which coordinates the alpha-phosphate group in previous ground state structures, is sequestered into coordinating the metal fluoride, thereby creating a charge environment complementary to the transferring phosphoryl group. In line with the dominance of charge balance in transition state organization, the substitution K219A induces a corresponding reduction in charge in the bound aluminum fluoride species, which changes to a trifluoroaluminate (AlF(3)(0)) complex. The AlF(3)(0) moiety retains the octahedral geometry observed within AlF(4)(-) TSA complexes, which endorses the proposal that some of the widely reported trigonal AlF(3)(0) complexes of phosphoryl transfer enzymes may have been misassigned and in reality contain MgF(3)(-).

Articles - 2wzb mentioned but not cited (12)

  1. Predicting new indications for approved drugs using a proteochemometric method. Dakshanamurthy S, Issa NT, Assefnia S, Seshasayee A, Peters OJ, Madhavan S, Uren A, Brown ML, Byers SW. J Med Chem 55 6832-6848 (2012)
  2. A spring-loaded release mechanism regulates domain movement and catalysis in phosphoglycerate kinase. Zerrad L, Merli A, Schröder GF, Varga A, Gráczer É, Pernot P, Round A, Vas M, Bowler MW. J Biol Chem 286 14040-14048 (2011)
  3. Mechanisms of protein sequence divergence and incompatibility. Wellner A, Raitses Gurevich M, Tawfik DS. PLoS Genet 9 e1003665 (2013)
  4. Thioredoxin-dependent redox regulation of chloroplastic phosphoglycerate kinase from Chlamydomonas reinhardtii. Morisse S, Michelet L, Bedhomme M, Marchand CH, Calvaresi M, Trost P, Fermani S, Zaffagnini M, Lemaire SD. J Biol Chem 289 30012-30024 (2014)
  5. The phosphoglycerate kinase 1 variants found in carcinoma cells display different catalytic activity and conformational stability compared to the native enzyme. Fiorillo A, Petrosino M, Ilari A, Pasquo A, Cipollone A, Maggi M, Chiaraluce R, Consalvi V. PLoS One 13 e0199191 (2018)
  6. Potent Anticancer Effect of the Natural Steroidal Saponin Gracillin Is Produced by Inhibiting Glycolysis and Oxidative Phosphorylation-Mediated Bioenergetics. Min HY, Pei H, Hyun SY, Boo HJ, Jang HJ, Cho J, Kim JH, Son J, Lee HY. Cancers (Basel) 12 E913 (2020)
  7. An allosteric signaling pathway of human 3-phosphoglycerate kinase from force distribution analysis. Palmai Z, Seifert C, Gräter F, Balog E. PLoS Comput Biol 10 e1003444 (2014)
  8. Sampling of Protein Conformational Space Using Hybrid Simulations: A Critical Assessment of Recent Methods. Kaynak BT, Krieger JM, Dudas B, Dahmani ZL, Costa MGS, Balog E, Scott AL, Doruker P, Perahia D, Bahar I. Front Mol Biosci 9 832847 (2022)
  9. Molecular mechanism of glycolytic flux control intrinsic to human phosphoglycerate kinase. Yagi H, Kasai T, Rioual E, Ikeya T, Kigawa T. Proc Natl Acad Sci U S A 118 e2112986118 (2021)
  10. The dipeptidyl peptidase IV inhibitors vildagliptin and K-579 inhibit a phospholipase C: a case of promiscuous scaffolds in proteins. Chakraborty S, Rendón-Ramírez A, Ásgeirsson B, Dutta M, Ghosh AS, Oda M, Venkatramani R, Rao BJ, Dandekar AM, Goñi FM. F1000Res 2 286 (2013)
  11. 1H, 15N, 13C backbone resonance assignments of human phosphoglycerate kinase in a transition state analogue complex with ADP, 3-phosphoglycerate and magnesium trifluoride. Serimbetov Z, Baxter NJ, Cliff MJ, Waltho JP. Biomol NMR Assign 11 251-256 (2017)
  12. Targeting phosphoglycerate kinases by tatridin A, a natural sesquiterpenoid endowed with anti-cancer activity, using a proteomic platform. Ferraro G, Voli A, Mozzicafreddo M, Pollastro F, Tosco A, Monti MC. Front Mol Biosci 10 1212541 (2023)


Reviews citing this publication (7)

  1. A structural perspective of compensatory evolution. Ivankov DN, Finkelstein AV, Kondrashov FA. Curr Opin Struct Biol 26 104-112 (2014)
  2. Metal Fluorides as Analogues for Studies on Phosphoryl Transfer Enzymes. Jin Y, Richards NG, Waltho JP, Blackburn GM. Angew Chem Int Ed Engl 56 4110-4128 (2017)
  3. Conformational dynamics in phosphoglycerate kinase, an open and shut case? Bowler MW. FEBS Lett 587 1878-1883 (2013)
  4. Metal Fluorides: Tools for Structural and Computational Analysis of Phosphoryl Transfer Enzymes. Jin Y, Molt RW, Blackburn GM. Top Curr Chem (Cham) 375 36 (2017)
  5. Phosphate analogues in the dissection of mechanism. Korhonen HJ, Conway LP, Hodgson DR. Curr Opin Chem Biol 21 63-72 (2014)
  6. Phosphoglycerate kinase: structural aspects and functions, with special emphasis on the enzyme from Kinetoplastea. Rojas-Pirela M, Andrade-Alviárez D, Rojas V, Kemmerling U, Cáceres AJ, Michels PA, Concepción JL, Quiñones W. Open Biol 10 200302 (2020)
  7. Reflections on biocatalysis involving phosphorus. Blackburn GM, Bowler MW, Jin Y, Waltho JP. Biochemistry (Mosc) 77 1083-1096 (2012)

Articles citing this publication (34)

  1. The energy landscape of adenylate kinase during catalysis. Kerns SJ, Agafonov RV, Cho YJ, Pontiggia F, Otten R, Pachov DV, Kutter S, Phung LA, Murphy PN, Thai V, Alber T, Hagan MF, Kern D. Nat Struct Mol Biol 22 124-131 (2015)
  2. Insulin and mTOR Pathway Regulate HDAC3-Mediated Deacetylation and Activation of PGK1. Wang S, Jiang B, Zhang T, Liu L, Wang Y, Wang Y, Chen X, Lin H, Zhou L, Xia Y, Chen L, Yang C, Xiong Y, Ye D, Guan KL. PLoS Biol 13 e1002243 (2015)
  3. Molecular insights on pathogenic effects of mutations causing phosphoglycerate kinase deficiency. Chiarelli LR, Morera SM, Bianchi P, Fermo E, Zanella A, Galizzi A, Valentini G. PLoS One 7 e32065 (2012)
  4. Near attack conformers dominate β-phosphoglucomutase complexes where geometry and charge distribution reflect those of substrate. Griffin JL, Bowler MW, Baxter NJ, Leigh KN, Dannatt HR, Hounslow AM, Blackburn GM, Webster CE, Cliff MJ, Waltho JP. Proc Natl Acad Sci U S A 109 6910-6915 (2012)
  5. Inducing phase changes in crystals of macromolecules: status and perspectives for controlled crystal dehydration. Russi S, Juers DH, Sanchez-Weatherby J, Pellegrini E, Mossou E, Forsyth VT, Huet J, Gobbo A, Felisaz F, Moya R, McSweeney SM, Cusack S, Cipriani F, Bowler MW. J Struct Biol 175 236-243 (2011)
  6. α-Fluorophosphonates reveal how a phosphomutase conserves transition state conformation over hexose recognition in its two-step reaction. Jin Y, Bhattasali D, Pellegrini E, Forget SM, Baxter NJ, Cliff MJ, Bowler MW, Jakeman DL, Blackburn GM, Waltho JP. Proc Natl Acad Sci U S A 111 12384-12389 (2014)
  7. A new variant of phosphoglycerate kinase deficiency (p.I371K) with multiple tissue involvement: molecular and functional characterization. Fermo E, Bianchi P, Chiarelli LR, Maggi M, Mandarà GM, Vercellati C, Marcello AP, Barcellini W, Cortelezzi A, Valentini G, Zanella A. Mol Genet Metab 106 455-461 (2012)
  8. Direct cryocooling of naked crystals: are cryoprotection agents always necessary? Pellegrini E, Piano D, Bowler MW. Acta Crystallogr D Biol Crystallogr 67 902-906 (2011)
  9. (19)F NMR and DFT Analysis Reveal Structural and Electronic Transition State Features for RhoA-Catalyzed GTP Hydrolysis. Jin Y, Molt RW, Waltho JP, Richards NG, Blackburn GM. Angew Chem Int Ed Engl 55 3318-3322 (2016)
  10. Charge-balanced metal fluoride complexes for protein kinase A with adenosine diphosphate and substrate peptide SP20. Jin Y, Cliff MJ, Baxter NJ, Dannatt HR, Hounslow AM, Bowler MW, Blackburn GM, Waltho JP. Angew Chem Int Ed Engl 51 12242-12245 (2012)
  11. Crystal structure of Plasmodium falciparum phosphoglycerate kinase: evidence for anion binding in the basic patch. Smith CD, Chattopadhyay D, Pal B. Biochem Biophys Res Commun 412 203-206 (2011)
  12. The catalytic mechanism of protein phosphatase 5 established by DFT calculations. Ribeiro AJ, Alberto ME, Ramos MJ, Fernandes PA, Russo N. Chemistry 19 14081-14089 (2013)
  13. Crystal structures of the novel cytosolic 5'-nucleotidase IIIB explain its preference for m7GMP. Monecke T, Buschmann J, Neumann P, Wahle E, Ficner R. PLoS One 9 e90915 (2014)
  14. Dissection of the difference between the group I metal ions in inhibiting GSK3β: a computational study. Lu SY, Jiang YJ, Zou JW, Wu TX. Phys Chem Chem Phys 13 7014-7023 (2011)
  15. Protein Stability, Folding and Misfolding in Human PGK1 Deficiency. Valentini G, Maggi M, Pey AL. Biomolecules 3 1030-1052 (2013)
  16. Insights into human phosphoglycerate kinase 1 deficiency as a conformational disease from biochemical, biophysical, and in vitro expression analyses. Pey AL, Maggi M, Valentini G. J Inherit Metab Dis 37 909-916 (2014)
  17. Interaction of human 3-phosphoglycerate kinase with its two substrates: is substrate antagonism a kinetic advantage? Lallemand P, Chaloin L, Roy B, Barman T, Bowler MW, Lionne C. J Mol Biol 409 742-757 (2011)
  18. Synthesis, structure and reactivity of a terminal magnesium fluoride compound, [TpBut,Me]MgF: hydrogen bonding, halogen bonding and C-F bond formation. Rauch M, Ruccolo S, Mester JP, Rong Y, Parkin G. Chem Sci 7 142-149 (2016)
  19. The interplay between protein stability and dynamics in conformational diseases: the case of hPGK1 deficiency. Pey AL. Biochim Biophys Acta 1834 2502-2511 (2013)
  20. Virtual Screening against Phosphoglycerate Kinase 1 in Quest of Novel Apoptosis Inhibitors. Xia J, Feng B, Shao Q, Yuan Y, Wang XS, Chen N, Wu S. Molecules 22 E1029 (2017)
  21. Crystal structures of putative phosphoglycerate kinases from B. anthracis and C. jejuni. Zheng H, Filippova EV, Tkaczuk KL, Dworzynski P, Chruszcz M, Porebski PJ, Wawrzak Z, Onopriyenko O, Kudritska M, Grimshaw S, Savchenko A, Anderson WF, Minor W. J Struct Funct Genomics 13 15-26 (2012)
  22. OptZyme: computational enzyme redesign using transition state analogues. Grisewood MJ, Gifford NP, Pantazes RJ, Li Y, Cirino PC, Janik MJ, Maranas CD. PLoS One 8 e75358 (2013)
  23. Structural determinants increasing flexibility confer cold adaptation in psychrophilic phosphoglycerate kinase. Mandelman D, Ballut L, Wolff DA, Feller G, Gerday C, Haser R, Aghajari N. Extremophiles 23 495-506 (2019)
  24. Nucleotide promiscuity of 3-phosphoglycerate kinase is in focus: implications for the design of better anti-HIV analogues. Varga A, Chaloin L, Sági G, Sendula R, Gráczer E, Liliom K, Závodszky P, Lionne C, Vas M. Mol Biosyst 7 1863-1873 (2011)
  25. Tying down the arm in Bacillus dUTPase: structure and mechanism. García-Nafría J, Timm J, Harrison C, Turkenburg JP, Wilson KS. Acta Crystallogr D Biol Crystallogr 69 1367-1380 (2013)
  26. Polyphosphate-containing bisubstrate analogues as inhibitors of a bacterial cell wall thymidylyltransferase. Smithen DA, Forget SM, McCormick NE, Syvitski RT, Jakeman DL. Org Biomol Chem 13 3347-3350 (2015)
  27. Assessing the Influence of Mutation on GTPase Transition States by Using X-ray Crystallography, 19 F NMR, and DFT Approaches. Jin Y, Molt RW, Pellegrini E, Cliff MJ, Bowler MW, Richards NGJ, Blackburn GM, Waltho JP. Angew Chem Int Ed Engl 56 9732-9735 (2017)
  28. Octahedral Trifluoromagnesate, an Anomalous Metal Fluoride Species, Stabilizes the Transition State in a Biological Motor. Ge M, Molt RW, Jenkins HT, Blackburn GM, Jin Y, Antson AA. ACS Catal 11 2769-2773 (2021)
  29. On the mechanism of phosphoenolpyruvate synthetase (PEPs) and its inhibition by sodium fluoride: potential magnesium and aluminum fluoride complexes of phosphoryl transfer. McCormick NE, Jakeman DL. Biochem Cell Biol 93 236-240 (2015)
  30. The relative hydrolytic reactivities of pyrophosphites and pyrophosphates. Mistry D, Powles N. Org Biomol Chem 11 5727-5733 (2013)
  31. Theoretical studies of cyclic adenosine monophosphate dependent protein kinase: native enzyme and ground-state and transition-state analogues. Leigh KN, Webster CE. Dalton Trans 43 3039-3043 (2014)
  32. Allomorphy as a mechanism of post-translational control of enzyme activity. Wood HP, Cruz-Navarrete FA, Baxter NJ, Trevitt CR, Robertson AJ, Dix SR, Hounslow AM, Cliff MJ, Waltho JP. Nat Commun 11 5538 (2020)
  33. MgF3- and AlF4- transition state analogue complexes of yeast phosphoglycerate kinase. McCormick NE, Forget SM, Syvitski RT, Jakeman DL. Biochem Cell Biol 95 295-303 (2017)
  34. Structural characterization of a novel cyclic 2,3-diphosphoglycerate synthetase involved in extremolyte production in the archaeon Methanothermus fervidus. De Rose SA, Isupov MN, Worthy HL, Stracke C, Harmer NJ, Siebers B, Littlechild JA, HotSolute consortium. Front Microbiol 14 1267570 (2023)


Quick links